Pine Valley Investments Ltd Liability Co Has $2.08 Million Stake in Axon Enterprise, Inc $AXON

Pine Valley Investments Ltd Liability Co raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 58.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,901 shares of the biotechnology company’s stock after acquiring an additional 1,799 shares during the period. Pine Valley Investments Ltd Liability Co’s holdings in Axon Enterprise were worth $2,081,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in AXON. Rockefeller Capital Management L.P. grew its position in Axon Enterprise by 53.2% during the fourth quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock worth $6,542,000 after buying an additional 4,002 shares in the last quarter. Legal & General Group Plc raised its holdings in Axon Enterprise by 1.3% in the 4th quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock valued at $242,241,000 after acquiring an additional 5,419 shares in the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $13,116,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of Axon Enterprise in the 1st quarter worth approximately $15,067,000. Finally, Harel Insurance Investments & Financial Services Ltd. grew its holdings in shares of Axon Enterprise by 40.7% during the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock worth $6,406,000 after purchasing an additional 4,360 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Elizabeth Reid Coughlin sold 1,554 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the transaction, the insider directly owned 34,024 shares in the company, valued at $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CRO Cameron Brooks sold 1,242 shares of Axon Enterprise stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the transaction, the executive directly owned 49,710 shares of the company’s stock, valued at approximately $24,855,000. The trade was a 2.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 58,989 shares of company stock valued at $30,527,983. 4.20% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. JPMorgan Chase & Co. boosted their price objective on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Piper Sandler lifted their price target on shares of Axon Enterprise from $674.00 to $724.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Zacks Research lowered shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. UBS Group lowered their price target on shares of Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Finally, Weiss Ratings upgraded shares of Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $725.25.

Axon Enterprise Trading Up 9.1%

AXON stock opened at $575.88 on Tuesday. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $885.91. The firm has a market cap of $46.42 billion, a P/E ratio of 231.28, a P/E/G ratio of 10.77 and a beta of 1.39. The business’s 50 day moving average is $500.89 and its 200-day moving average is $475.06. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping the consensus estimate of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. During the same quarter last year, the company earned $1.47 EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.